Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE: Apremilast plus phototherapy vs phototherapy alone in psoriasis vulgaris
jRCTs041180012Completed
- Sponsor
- Amgen
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of apremilast in plaque psoriasis and psoriatic arthritis (PsA) (2 arms), sponsored by Amgen. Started Dec 2018; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on jRCTs041180012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180012.